{"name":"SynDevRx, Inc.","slug":"syndevrx-inc","ticker":"","exchange":"","domain":"","description":"SynDevRx, Inc. is a clinical-stage biopharmaceutical company focused on the development of novel therapies for serious and life-threatening diseases. The company's lead candidate, SDX-7320, is currently in Phase 2 clinical trials.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMikAJBVV95cUxNNUhYMTBicVpxMjBZQXhXRlNSZHptSlY5cUc5YTBmUlUwUHRaZW9NRE1OMzI5VVFTZ2VwcHlVb1VUOWFpU3cxNi1tUUI3VWRTMW5fdzU5a3BuZ2lMdDBTMVozZ2lMVS11c0NlYzR5ck1pS2lYTEgxOWM3X2h3QjVFR0VQNE9qUmFOeEFMVE9Tc2FYWS1qeUxZNGRkZDZxXzFhcDlSd2JwNUZpOUl3OUM2NWI4RWYzY0hwRmVjcmphc25tYTZfek5LNnhZbXFhbEtwUTM3TDg2Rk1mbnFOOUJHa01XVWZIM1RkOXZYOTM5NldDVFZKc1pRcUxaOGhTeWJQUXRtNzhIRHVURXExLUIwVg?oc=5","date":"2024-03-28","type":"pipeline","source":"BioSpace","summary":"Cambridge-Based Biotech SynDevRx Announces Scientific Publication Describing Optimized Drug Conjugate Targeting Tumors Sensitive to Obesity/Metabolic Hormones - BioSpace","headline":"Cambridge-Based Biotech SynDevRx Announces Scientific Publication Describing Optimized Drug Conjugate Targeting Tumors S","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxPSkhweXZOTjNEWjhCVVhSMXQ0RFpVRS1panh2R0EwMm1uOFFSYW1xUGJ1a1VBc2ZKNzc5b09JV2RxX1J3WlduUXQ1V1FqSWFVTWpuS1VjdGNaMmduQXdMQkdLTlNSZXo4Z3FTVWZVWllnbXppdTJ5TkxEZWlKcDlfU3gtUjh2aXlVU0pSc0ppODR1dw?oc=5","date":"2012-06-04","type":"pipeline","source":"Technology Networks","summary":"Ariana® Expands Operations to USA - Technology Networks","headline":"Ariana® Expands Operations to USA","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}